Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscular Dystrophy, Landouzy Dejerine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07478172
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who this might be right for
Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more
University of Missouri-Columbia 50
Testing effectiveness (Phase 2)Looking for participantsNCT06131983
What this trial is testing

Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Sarepta Therapeutics, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT02836418
What this trial is testing

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular DystrophyLimb Girdle Muscular Dystrophy
aTyr Pharma, Inc. 8
Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Not applicableActive Not RecruitingNCT03458832
What this trial is testing

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University of Kansas Medical Center 324
Not applicableLooking for participantsNCT05019625
What this trial is testing

Biomarker Development for Muscular Dystrophies

Who this might be right for
Myotonic DystrophyDuchenne Muscular DystrophyBecker Muscular Dystrophy+1 more
Massachusetts General Hospital 465
Not applicableEnrolling By InvitationNCT07164937
What this trial is testing

Imaging and Gait Analysis in FSHD Patients

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Not applicableLooking for participantsNCT04369209
What this trial is testing

A Registered Cohort Study on FSHD1

Who this might be right for
Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
Ning Wang, MD., PhD. 1,000
Not applicableActive Not RecruitingNCT05453461
What this trial is testing

ADVANCED FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot Study

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Centre Hospitalier Universitaire de Nice 30
Testing effectiveness (Phase 2)Study completedNCT02603562
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
aTyr Pharma, Inc. 8
Testing effectiveness (Phase 2)Ended earlyNCT03943290
What this trial is testing

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

Who this might be right for
Facioscapulohumeral Muscular DystrophyCharcot-Marie-Tooth Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 62
Testing effectiveness (Phase 2)Ended earlyNCT04004000
What this trial is testing

Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Fulcrum Therapeutics 14
Not applicableStudy completedNCT04694456
What this trial is testing

Pro-inflammatory Cytokines in Facioscapulohumeral Muscular Dystrophy (CYTOKINE-FSH)

Who this might be right for
Muscular Dystrophies
Centre Hospitalier Universitaire de Nice 30
Not applicableStudy completedNCT07331025
What this trial is testing

Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings

Who this might be right for
Facioscapulohumeral Muscular DystrophyFacioscapulohumeral Muscular Dystrophy 1Neuromuscular Disease
Koç University 39
Not applicableLooking for participantsNCT06911190
What this trial is testing

Ten Year Follow-up in FSHD: the FOCUS 3 Study

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Radboud University Medical Center 200
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableStudy completedNCT01437345
What this trial is testing

Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Cooperative International Neuromuscular Research Group 53
Testing effectiveness (Phase 2)Ended earlyNCT02927080
What this trial is testing

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 95
Not applicableStudy completedNCT02625662
What this trial is testing

Facioscapulohumeral Dystrophy in Children

Who this might be right for
Neurological ObservationsFacioscapulohumeral Muscular DystrophyPediatric Disorder
University Medical Center Nijmegen 32
Large-scale testing (Phase 3)Looking for participantsNCT07038200
What this trial is testing

Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

Who this might be right for
Facioscapulohumeral Muscular DystrophyFSHDFSHD - Facioscapulohumeral Muscular Dystrophy+14 more
Avidity Biosciences, Inc. 200
Next Page